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1. INTRODUCTION
Retinal dystrophies have a high impact on a patient’s life: reduced central and or peripheral vision,
night blindness, photophobia and/ or even blindness can occur depending on diseased retinal cells
and retinal area. The macula area, only or primarily, is affected in a subset of retinal dystrophies.
Stargardt macular dystrophy1 (STGD1) is one of the most common hereditary macular dystrophies2,
whereas age-related macular degeneration (AMD) is the leading cause of ‘elderly’ blindness in
developed countries.3
Phenotype characterization is essential to identify the type of retinal dystrophy for patient
information and counseling. Phenotype identification will guide molecular-genetic investigations
based on specific features of the underlying retinal changes. The next aim is retinal morphology and
function quantification over time to understand the longitudinal natural disease course. Of major
interest are early disease stages. In particular children need special attention and technical setups for
collecting data. Our focus was to develop a method, which would allow imaging infants and
children for retinal morphology analysis. Once the disease causing mutation is identified, genotype-
phenotype correlation is the next step in studying retinal dystrophies. New promising trials in retinal
dystrophies are arising. For this, objective outcome measures are a necessity for successful
therapies.
Retinal function and morphology are the two foundations of phenotypic characterization. Retinal
function can be measured objectively by electroretinography. The multifocal electroretinogram
(mfERG) allows a detailed mapping of retinal and macular function. First, no detailed knowledge of
age-related changes in mfERG responses and their origin was available. Investigations into the
natural aging process allowed longitudinal studies in different age groups to be made.
Studies of in-vivo retinal morphology were limited by technical properties. Optical coherence
tomography (OCT)4, a fairly new in-vivo imaging technique in ophthalmology permits visualizing
of retinal morphology in cross-sectional scans [reviewed in5] and, with the use of more advanced
reconstructing programs in 3-D view similarly to a CT scan.6 We used this technique to quantify
macular dystrophies together with retinal function in a wide range of retinal and macular
dystrophies.
This work summarizes research performed during my residency at the University of Regensburg,
the research fellowships and visits at the Vision Science and Advanced Retinal Imaging Laboratory
(VSRI) at the Department of Ophthalmology and Vision Science, University of California, Davis,
USA and the Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children in
Toronto, Canada.
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2. METHODS
2.1. Multifocal electroretinography (mfERG)
2.1.1. Basic principles
Electroretinography (ERG) using different stimulus and background light intensities allows
measuring retinal activity. It is a standard measure in vision science to quantify retinal cell
function.7 ERGs can be recorded from the entire retina by using a flash stimulus (fullfield ERG) or
from areas with a focal stimulus. The multifocal technique introduced by Sutter and Tran8 permits
recordings of multiple, spatially localized ERGs and therefore, mapping of macular function. Hood
et al.9 showed that the first-order kernel response in photopic mfERGs is generated from the cone
photoreceptor cells and the ON- and OFF bipolar cells. Localized abnormal retinal responses, which
are undetected by the fullfield ERG can now be identified and mapped using the mfERG.  103
individual hexagonal areas within a retinal area of 15-25 degrees in radius (about the area of the
posterior pole containing most morphological changes in macular dystrophies) can be tested and
mapped. This technique is therefore useful and efficient, in detecting abnormal responses in the
early stage of disease, in mapping abnormal responses in the cone-driven pathways and in
monitoring disease progression.
2.1.2. MfERG recording
MfERG responses were recorded according to the recommended ISCEV guidelines for basic
mfERG.10 We used a 103 hexagon stimulation (Fig.1) displayed on a VERISTM stimulus-refractor
unit (frame rate 75 Hz) or on a large screen11 and a standard m-sequence length with m=14. Signals
were sampled at 1200 Hz (i.e. 0.83 ms between samples). Stimulus luminance ranged between 135
and 700 cd . m–2 (white) and <1 cd . m–2 cd (black). Data were acquired at a gain of 105 over a
frequency range of 10-300 Hz. All mfERGs were recorded monocular with dilated pupils using a
bipolar Burian-Allen electrode and an electrode placed on the forehead as a ground electrode.
Subjects were asked to focus on a fixation target displayed within the stimulus array, or, in case of
reduced visual acuity, in the middle of an enlarged cross.
First-order kernel mfERG responses were analyzed for response density (density scale average
obtained from the first negative trough to the first positive peak) and implicit times (first and second
negative through and first positive peak). (Fig. 1)
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Figure 1: MfERG stimulus pattern of 103 hexagons (left) and resulting retinal responses in a
control subject shown (middle). Single MfERG responses are analyzed for response density P1-N1
and implicit times N1, P1 and N2 (right).
There are different options for response analysis. Each of the single mfERG response can be
analyzed separately or grouped into areas or concentric rings. The latter way of analysis is
advantageous for recordings with small signals or low signal-to-noise ratio (SNR) and for
calculating ratios. The disadvantage of grouping is the loss of the localized response characteristic,
the strength of the mfERG. We applied the concentric ring analysis in order to visualize age-related
changes in a normative data group topographically.12, 13 We also analyzed mfERG data from
patients with Stargardt Macular Dystrophy in the same way to overcome the problems of small
signals from diseased retinal areas.11 Further analysis of patient data was performed for each retinal
area stimulated after carefully controlling for SNR.14-16 A localized analysis allowed correlations
with morphological retinal changes.
Patients with severe or advanced retinal dystrophies show only small retinal responses when tested
with the mfERG. (Ref. 6)16 Data analysis need to consider careful exclusion of noise and artifacts
within the signal. (Ref. 7)17
2.1.3. Age-related response changes
The knowledge of normative data and its age-related change is fundamental for interpretation of
patient data. Histological data revealed a cone photoreceptor density loss with age.18 Fullfield ERG
responses showed a linear change in amplitude and latency.19-21 We therefore hypothesized that
retinal responses from the central retina show similar changes with age as indicated by
psychophysical experiments.22 We tested 81 subjects ages 9 to 80 years to investigate the age-
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related changes depending on retinal topography. (Ref. 2)12 All subjects were free of any retinal or
optical media changes.
An example of mfERG responses of a 16- and a 72-year old control subject is shown in Fig. 2.
We found a significant decline in retinal responses with age for all retinal areas with the steepest
slope in the central response compared with extrafoveal responses. (Fig. 3) Implicit time P1
changed with age but there was no difference with retinal topography.
     
Figure 3: Log response density is plotted
as a function of age for different
concentric retinal areas stimulated.
Least-squares linear regression lines are
shown for each data set.
Figure 2: Central retinal mfERG
responses of a 16- (left panel) and a 72-
year old subject (right panel)
demonstrate an obvious decline with age.
Trace arrays (bottom) with
corresponding response density plots (top
row) show a larger reduction in the
central than in the peripheral responses.
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Are the age-related changes in retinal responses different for different luminances? All subjects
were tested twice, with 200 cd . m–2 and 700 cd . m–2 white stimuli. The rate of change with age was
not significantly different for the two testing conditions indicating a stable visual system for the
luminances tested.
A previous publication investigating the aging effect on retinal responses claimed it to be caused by
optical factors.23 We hypothesized that some but not all aging effects are caused by optical factors,
but an important part are caused by neural factors in the visual system.
We simulated the effect of increasing scatter and loss of contrast and retinal illuminance due to
optical changes with age. After subtracting those effects from the mfERG response, there was still a
change, which can be attributed to senescent changes within the cone pathways.
These results have an important impact on the analysis of mfERG data. Studies performed in a
patient cohort of different ages need to compare the data with a detailed normative database
obtained on the same recording system and under the same recording conditions. Longitudinal
studies of elderly patients, who receive cataract surgery during the observation time, need to take
the changed optical media into account for data interpretation.
The first-order kernel mfERG response is far more complex than a fullfield ERG response. Lateral
and temporal retinal interactions occur because of the fast stimulation of multiple retinal areas. The
mfERG response contains the response to the stimulus (isolated flash response) and induced
components from previous and following flash responses (backward and forward interaction).24 We
investigated the effect on mfERG responses for different interactions to get insight in the origin of
retinal response aging within the cone pathways. (Ref. 3)13 Our detailed analysis of mfERG
response components revealed a senescent change in the isolated flash response more than in
consecutive flash interactions. Optical and neural factors are responsible for this aging decline, with
the latter over weighting the first. We then repeated the analysis for the same retinal area that we
had tested with psychophysical measures.25 Both responses, the isolated flash response elicited by
the mfERG and the impulse response function using a double-pulse method, indicated a response
amplitude decline and a small but significant increase in implicit time. Thus, the aging effect occurs
early in the visual system, the retina. Adaptive mechanism, such as gain control within the visual
system might compensate for some but not all of the aging effect in the retinal response.26
The results provide the basis for further studies in patients with macular dystrophies.
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2.2.     Optical coherence tomography (OCT)
2.2.1. Basic principles
The underlying principle of the OCT is to image biological tissue trough the reflection of light. It is
in contrast to the ultrasound technique a non-contact application. The application of light allows a
much higher resolution than ultrasound. Light of 200-600 nm and above 1000 nm wavelength is not
used because of tissue absorption by hemoglobin and water, respectively. A light beam, mostly
around 800 nm wavelength, is swept across biological tissue. The reflected light is collected and its
time-delay measured in comparison with a sample reflection by a Michelson interferometer.4 The
axial resolution is depending on the spectral bandwidth and therefore limited by the development of
superluminescent diode. The lateral (transverse) resolution is determined by the optical system to
minimize the spot size.
Two main OCT technologies are available: the Time and Fourier domain OCT.
In Time domain OCT, the OCT signal is measured as a function of reference mirror position. In
Fourier-domain (FD) OCT the position of the reference mirror is stationary with resulting higher
acquisition speed. Signals in FD-OCT systems are detected in Fourier space and then inverse
Fourier transformed.
Figure 4: 6 mm horizontal FD-OCT scan through the macula of a control subject. Retinal layers:
CL, connecting cilia; GCL, ganglion cell layer; ILM/ NFL, internal limiting membrane/ nerve fiber
layer; INL, inner nuclear layer; IPL, inner plexiform layer; ISL, inner segment layer; OLM, outer
limiting membrane; ONL, outer nuclear layer; OPL, outer plexiform layer; OSL, outer segment
layer; RPE/BM, retinal pigment epithelium/Bruch’s membrane; VM, Verhoeff’s membrane.
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The OCT system developed and built at the VSRI is a high-speed FD-OCT27 with a fast acquisition
time (1000 A-scans/ frame, 9 frames/sec)  and high resolution (axial 4.5 m) allowing high-quality
imaging in a short time.
This system with high-resolution properties provides image acquisition at near histological level.
Single retinal layers are visible and distinguishable in each of the scans as demonstrated in Fig. 4.
2.2.2. Mode of application
In the conventional setup patients sit with their head on a chin rest as for a slit-lamp examination.
The available table-mounted OCT systems and the necessity of a chin rest do not easily permit
scanning in infants and children. We were able to overcome this in collaboration between the VSRI
at UC Davis and the Department of Ophthalmology and Vision Sciences at the Hospital of Sick
Children in Toronto. (Ref. 14)28 We used a handheld probe in 2 ways. Children old enough to sit or
stand with their head positioned quietly on a chin rest were imaged with the probe mounted on a
slit-lamp stand. We used the probe like a hand-held camera for imaging under sedation and in
children, who were too young or restless be examined on the mounted system. (Fig. 5)
Figure 5: The hand-held scanner mounted on a slit-lamp post (left panel) was used for older
children. Younger children, not able to sit quietly, and children under sedation (right panel)
were imaged in a supine position with the scanner in hand-held mode.
28
We were able to image successfully all 30 children included in the study with or without retinal
pathology who ranged in age from 7 months to 9.9 years. All children tolerated the procedure well.
Children as young as 3 years were able to hold still for image acquisition. We dilated the pupils in
most of the children. Some, who did not want eye drops, were cooperative enough to be imaged
successfully with undilated pupils.
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Slower acquisition systems do not permit imaging subjects with unstable fixation or children. The
fast acquisition time of the FD-OCT system used permitted a high image quality despite the
sometimes limited attention range. We were able to image children or patients with severely
reduced vision and/ or nystagmus.29-31 Retinal layer resolution in children was similar to that
obtained in adults.
Identification of retinal pathology in children imaged was important to exclude non-organic vision
loss, quantify abnormal retina layers and complement the clinical diagnosis. In one 7-year old girl,
who lost vision due to Leber Congenital Amaurosis, caused by a mutation in the RPE65 gene, we
identified well-preserved inner retinal layers despite nystagmus and unsteady fixation. Outer and
inner segment layer were not distinguishable in her macula. This knowledge will be important in
upcoming treatment trials to monitor outcome.
2.2.3. Data analysis
Retinal layer thickness and morphological changes can be measured and qualitatively analyzed.
Raw OCT data undergoes post-processing and reconstruction to obtain en-face fundus OCT scans.
A series of B scans is acquired over a retinal area. The system we used was set to obtain 1000 A
scans for one B scan. A series of 100 B scans were acquired over an area of 6 x 6 x 2 mm volume of
retina. An example of a B scan series is shown in Figure 6. This volumetric scan series can be used
for OCT fundus reconstruction and spatial identification of retinal layers abnormalities. (Fig. 7)
Figure 6:
Selected images from
100 B scans of the
central macula in a
control subject.
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3. RESULTS OF PHENOTYPE CHARACTERIZATION
In the following, data of phenotype characterization in patients with different macular dystrophies
are described. Genotype was available in all but two disease entities; age-related macular
degeneration (AMD) and membrano-proliferative glomerulonephritis type II.
The initial projects in patients with AMD were focused to quantify retinal dysfunction, it’s
progression and relation to fundus morphology. Further investigations were performed in patients
with macular dystrophies, which share the signs of ‘retinal deposit disease’: Stargardt Macular
Dystrophy, autosomal dominant drusen, membrano-proliferative glomerulonephritis type II and
autosomal recessive bestrophin retinopathy.
Patients with cone-rod dystrophies very often show an associated maculopathy. We therefore
included patients with Bardet-Biedl-Syndrome in the imaging study.
X-linked retinoschisis, shows an early disease onset similar to Stargardt Macular Dystrophy but
mostly without progression. It is considered as a vitreo-retinal dystrophy. There, we examined the
retinal, specifically the photoreceptor changes with different ages.
3.1. Age-related Macular Degeneration (AMD)
An early sign of AMD are large drusen, which are highly predictive of late stage disease.3, 32 Those
deposits originating from photoreceptor outer segments are localized between the retinal pigment
epithelium (RPE) and the inner collagenous zone of Bruch’s membrane.33 Histological data
identified disrupted, rearranged and atrophic photoreceptors adjacent to and /over drusen.33-35 We
investigated the extent of retinal dysfunction measured by mfERG and its correlation to
morphology. (Ref. 4, 5)14, 15 20 patients (31 eyes) ages 58 to 84 years with 5 large drusen were
Figure 7: Volumetric scan
from 100 horizontal
macular B scans overlaid on
a fundus in a patient with
EFEMP1 associated
macular dystrophy.
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included in the study. The change in response amplitude and implicit time in patients with large
drusen who often retained visual acuity can be very small as illustrated in the example in Figure 8.
Figure 8: Example of mfERG responses from a 68-year old patient with large drusen and visual
acuity of 20/20 (green traces) compared with a 77 year old control subject (black traces).
Here, we applied a localized response analysis of each of the 103 mfERG responses. Response
averaging over a retinal area would have smoothed most of the abnormal responses due to the very
distinct characteristics. Our data indicated that implicit times were more often abnormal than
response amplitudes. Comparing different implicit times, N2 was more often delayed than N1 or P1.
                                
                         
                            
Figure 9: Example of 3 eyes with retinal dysfunction not confined to the drusen
area visible on the fundus photography (top row). Results of scalar products (SP)
(middle row) and implicit time P1 (bottom row) illustrating extended retinal
dysfunction. Color code: reduced SP < 2SD in dark blue, delayed P1 >2SD in red.
SP
P1
# 14# 3 # 5
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Theses data suggest an earlier dysfunction in outer retinal cells other than photoreceptors.
Functional data were correlated with the area of drusen measured on red-free fundus photography.
Response abnormalities were found beyond morphological changes up to the entire retinal area
tested. (examples in Fig. 9) We detected a significant correlation of drusen area and retinal
responses in only a few patients. Those results indicate that patients with early stage AMD already
have compromised function within the cone-driven pathways. The extent of dysfunction is not
reflected by the ophthalmoscopically visible drusen but is more general over the retinal area.
We were then interested in the longitudinal disease course and re-tested most of the patients who
participated initially after a follow up of 28 to 41 months. (Ref. 5)15 MfERG results demonstrated a
significant deterioration in all response components. (Fig. 10)
Figure 10: Significant changes in implicit times N1, P1 and response density P1-N1at baseline
(green histograms) and follow up (superimposed red histograms). Bold lines indicate the point of
significant abnormal responses.
The most dramatic response decline was evident in response density reduction, which was not
confined to the central retina. Morphological analysis revealed drusen progression, unchanged
drusen or drusen regression with an increase of RPE atrophy. Retinal function, in particular implicit
times, behaved differently in those 3 groups. It appeared that drusen regression is associated with
further implicit time delays.  Thus, mfERG is a very useful tool quantifying retinal function in
patients with early stage AMD. MfERG responses might be an important outcome measure in
further studies and treatment trials. (Ref. 8) 36 Care, however, must be taken in data acquisition and
data analysis. Comparison with age-matched control data, control for noise level17 and a localized
analysis approach are basis for successful interpretation.
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3.2. Stargardt Macular Dystrophy
Stargardt Macular Dystrophy1 (STGD1, OMIM248200) / Fundus flavimaculatus (FFM) is one of
the most common hereditary macular dystrophy with a juvenile onset. It accounts for about 7% of
all retinal dystrophies.2 It often presents as a subacute but progressive decrease in visual acuity with
a poor final visual outcome. One of the first clinical signs is a blunting of the foveal reflex.  The
macula can become progressively atrophic with a “beaten bronze” or “bull’s eye” appearance.
Classically, this is associated with a variable distribution of yellowish “pisciform” deep retinal
flecks.37-40 Central scotomas are the most common visual field abnormality.
STGD1 and FFM are different phenotypic severities caused by mutation in the ABCA4 gene.41 The
same gene might play a role in the development of AMD, but this fact is discussed
controversially.42-44
To determine the functional effect of ABCA4 mutations in vivo, we investigated retinal function in
16 genotypic identified patients with STGD1/ FFM using psychophysical (visual acuity, color
vision, two-color static perimetry) and electrophysiological measures (fullfield ERG, mfERG).
(Ref. 1)11 Perimetry data indicated dysfunction in the cone pathways in all but one patient tested.
Fullfield ERG responses were within normal range in most of the patients. Abnormal mfERG
responses, in contrast, reflected the predominantly affected central retina. Reduced response
densities were found in all and delayed P1 implicit time in 80% of the patients. Even in early stages
of the disease with still good visual acuity, we were able to reveal a significant response delay and/
or reduction using the mfERG test. (Fig. 11)
     
Figure 11: Autofluorescence (AF) image of the right macula and mfERG response array
elicited from the same fundus area in a patient with compound heterozygous ABCA4 mutation.
Visual acuity: 20/40. Only central mfERG responses are reduced. Ring of increased AF
surrounding a central reduced AF corresponding to increased lipofuscin and loss of RPE,
respectively.
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Reduced mfERG responses identified the affected stage in the cone driven pathways, namely
photoreceptor and bipolar cells.  Thus, reduced sensitivity on two-color perimetry is caused by a
dysfunction at an early stage of the cone pathways, within the outer retinal cells.
There was a significant association between disease duration and retinal function. Functional
mfERG data together with psychophysical measures of cone and rod mediated function correlated
with the present genotype. We found greater disease severity in patients with a homozygous
mutation and compound heterozygous mutation with predicted loss of allelic function. Milder
phenotype was evident in patients harboring less severe mutations with predicted partial protein
activity.
The hallmark of STGD1 is the loss of foveal photoreceptors and the accumulation of lipofuscin
granules in RPE cells as shown in histological sections by Birnbach et al. (Fig 12)40
In the pre-OCT era, no in-vivo method was available to visualize these changes within different
retinal layers. Lipofuscin accumulation within the RPE cells can be shown indirectly by the
Figure 12:Histological sections through the
retina of a patient with STGD1 demonstrate
lipofuscin accumulation within RPE cells. (left
panel).
39
 In vivo macular FD-OCT scans
identified similar deposits in a patient with
STGD1. (lower panel: A/B)  Photoreceptor loss
is visible in the central area (white arrows).
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demonstration of increased autofluorescence.45 (example in Fig. 11) The morphology of
photoreceptor cells cannot be identified with this investigation. OCT, in particular high-resolution
OCT techniques permit the identification of small retinal cell changes and the localization of retinal
deposits. We showed for the first time retinal deposits of lipofuscin in a patient with STGD1. (Ref.
9)46 (Fig. 12)
The comparison with Birnbach’s40 observations is striking. A similar shape and location of the
deposits is shown in the retinal layer analysis. Outer retinal layers demonstrate changes sharply
confined to the central macula: the outer nuclear layer is thinned or not identifiable, the inner and
outer segment layers, connecting cilium and Verhoeff’s membrane are not distinguishable. The
lipofuscin deposits are within the RPE cell layer and ‘replacing’ outer retinal layers. Inner retinal
layers are not affected in the patients who were tested. (unpublished data and 46) (Fig. 12)
Based on these data it is now possible to correlate retinal function with detailed in-vivo acquired
retinal abnormalities in STGD1.
3.3 Autosomal dominant drusen
Autosomal dominant drusen (ADD) (OMIM 126600) were originally described in two different
geographical regions as Doyne Honeycomb Retinal Dystrophy (DHRD) in England47 and Malattia
Leventinese (MLVT) in Switzerland.48 A single missense mutation Arg345Trp in the EFEMP1
gene has been identified in both DHRD and MLVT.49 Fundus changes show retinal deposits
different in size and distribution compared with STGD1.  Here, characteristic signs are early onset
drusen at the posterior pole and peripapillar area with radial distribution and increasing confluence
with age. Large cohort studies demonstrated phenotypic inter- and intrafamilar variability.50, 51
Vision function is better preserved than in STGD1. In a mild phenotype, diagnosis is made through
a routine eye exam in patients without symptoms.
Multifocal ERG recording can reveal central cone-mediated dysfunction as shown in the case of a
30-year old patient with minimally reduced visual acuity (Snellen acuity 0.9) but obvious fundus
changes. (Ref. 13)52 Fullfield ERG data were within normal range. MfERG results revealed reduced
and delayed responses within the central 20 degrees retinal eccentricity. (Fig. 13) With the well-
preserved visual acuity one would not have expected such dramatic changes in the macular function
detected by mfERG.
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Figure 13: MfERG trace arrays from a 30-year old patient with EFEMP1 associated macular
dystrophy. Central responses are severely reduced. Some of the responses are not distinguishable
from noise. Responses between 20° and 25° retinal eccentricity are within normal range.
What are the associated retinal cell abnormalities and are those different from investigations in
STGD1? Retinal layer analysis in EFEMP1 associated macular dystrophy showed small to
extensive deposits within the sub RPE cells. Bruchs membrane is separated from RPE cells. Outer
retinal layers are elevated by the dense deposits and partially disrupted. Outer nuclear, inner and
outer segment layers are thinner and sometimes not distinguishable. (Fig. 14)
  
Figure 14: Serial horizontal FD-OCT scans of 2 patients with EFEMP1 associated macular
dystrophy demonstrate mild (left panel) to extensive (middle panel) deposits in the sub RPE space.
Reconstructed C scan at the level of the photoreceptor inner/outer segment junction. (right panel)
Inner retinal layers are undisturbed and intact. Volumetric scans as shown in Fig. 7 permit
reconstruction of C scans of different retinal layers. Identification of deposits at the connecting
cilium layer, the junction between inner and outer segments, was made possible through this C scan
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and demonstrated the dimension of associated pathology. Photoreceptor disruption is confined to
areas with sub RPE deposits. (Fig. 14)
3.3. Membrano-proliferative glomerulonephritis type II
Membrano-proliferative glomerulonephritis type II (MPGN type II or dense deposit disease53) is a
rare disease affecting multiple systems such as kidneys (nephritic syndrome), heart (heart
insufficiency), subcutaneous fat (lipodystrophy) and the retina (stable54 to progressive55
retinopathy).56 MPGN type II is characterized by dense deposits within the glomerular basement
membrane in the kindney and Bruch’s membrane and choriocapillaris in the retina.57, 58
The retinal deposits are drusenoid and similar to autosomal dominant drusen.
We investigated the retinal localization and associated retinal layer disruption in different disease
severities. (Ref. 1259 and unpublished data)
A family of three daughters and their mother showed distinct drusenoid deposits in the macular area
of different distribution on a routine eye exam. Retinal function including visual acuity was normal.
Kidney function was slightly abnormal suggesting MPGN type II. FD-OCT images revealed small
Figure 15: Examples of MPGN type II macular
dystrophy of different extent. Left panel shows 4
family members with macular deposits identified
within the inner retina on FD-OCT and disrupted
foveal photoreceptors. (unpublished data, presented
at the ISGEDR meeting 2008) More advanced
macular dystrophy and deposit disease within outer
retina layers are shown on the right.
58
41 yrs
9.7 yrs
8.3 yrs
6.3 yrs
54 yrs
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round deposits within the inner retinal layers. (Fig. 15) Of interest is the analysis of the foveal
scans: disrupted Verhoeff’s membrane was evident in all 4 patients. A more severe systemic and
retinal phenotype was present in a 54 year old patient. In this case, we found dense deposits within
the RPE/ Bruch’s membrane protruding into outer retinal layers. Photoreceptor layers were
disrupted not only in areas of retinal deposits but also in the foveal and macular areas without
visible deposits. (Fig. 15)
3.4. Autosomal recessive bestrophin retinopathy
Best macular dystrophy60 is an autosomal dominant macular dystrophy with variable phenotype and
disease onset. Mutations in the BEST1 gene are identified as disease causing.61-63 The characteristic
features are retinal deposits within the subretinal space, visible as ‘egg yolk’ lesions on
ophthalmoscopy. Time-domain OCT localized retinal deposits within the outer retina or in the
subretinal space.64 A new type of macular dystrophy associated with biallelic mutations in the
BEST1 gene is referred as autosomal recessive bestrophin retinopathy (ARB).65 Typical changes are
multiple retinal deposits within the macula and possibly in the periphery.  (Fig. 16) The deposits are
Figure 16: Fundus images of the left eye shows multiple yellowish-white deposits within
the macular area. Central mfERG responses are reduced and delayed (top row). OCT
fundus at the level reconstructed at the level of the connecting cilium illustrated abnormal
structure (bottom, left image). B scan OCT images reveal photoreceptor elongation and
detachment and deposits within the RPE ‘erupting’ through outer retinal layers.
Macular dystrophies: role of mfERG and FD-OCT
22
different from autosomal dominant drusen, drusen in AMD or from the flecks seen in STGD1. In
ARB, the deposits seem to be in deeper retinal layers and more indistinct. The RPE function is
reduce as indicated by abnormal light rise and reduced Arden ration in electro-oculogram testing.
We examined function and morphology in ARB to compare the changes with other retinal deposit
diseases. (Ref. 15)66 MfERG showed reduced and delayed responses within 10° retinal eccentricity.
Normal mfERG responses between 10° to 25° were detected in areas with obvious fundus changes
and retinal deposits. Normal visual acuity was found despite clear photoreceptor elongation in the
foveal area. Deposits were very prominent reaching from the RPE into the subretinal space. (Fig.
16)
3.6. Maculopathy associated with retinopathy in Bardet-Biedl-Syndrome
Bardet-Biedl Syndrome (BBS) is a multi-systemic disorder with polydactyly, kidney abnormalities
or dysfunction, retinopathy, obesity, learning disabilities or severe cognitive impairment.67-70
Retinal dystrophy in patients with BBS includes a maculopathy in association with a generalized
cone-rod dystrophy in most cases. The main research interest is the connecting cilium of the outer
retina since BBS is thought to be a ‘ciliopathy’.71, 72 Functional data indicated a parallel but more
severe disease progression in patients with mutations in BBS10.73 No mfERG data are available in
the patient group investigated with FD-OCT. Low visual acuity, nystagmus or attention or mental
impairment did not allow successful mfERG recording.
We investigated retinal layer composition in patients with mutations in BBS1 or BBS10, the most
common disease causing mutations in BBS. (Ref. 11)29 Results indicate predominant changes
within outer retinal layers. Inner retinal layers showed normal configuration in all but one patient
tested. This patient showed a severe retinopathy and maculopathy with reduced visual acuity to 0.05
(Snellen acuity). Outer retinal layers demonstrated preserved outer nuclear layers but thinned or
indistinguishable outer and inner segment layers.
Connecting cilium was not identifiable in all patients scanned. Of interest are retinal deposits above
or adjacent to Bruch’s membrane. (examples in Fig. 17) Clinically, no retinal deposits such as seen
in macular dystrophy described above were evident in patients with BBS. We presumed that the
deposits are secondary to retinal degeneration as seen in patients with retinitis pigmentosa.74 More
severe retinal changes were found in patients with BBS10 than BBS1 mutation. A faster rate of
progression might account for the retinal micro-structural advanced abnormalities in BBS10
mutations.
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Figure 17: Comparison of retinal morphology in patients with mutations in BBS1 and
BBS10 revealed more advanced outer and inner segment atrophy, thinner RPE cell
layer and more deposits above Bruch’s membrane in patients with BBS10.
3.5. X-linked Retinoschisis
X-linked Retinoschisis (XLRS)75 caused by mutation in XLRS176 is a predominant macular vitreo-
retinal dystrophy with splitting of the retina. (Fig. 18)
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Patients are of similar age or younger compared with patients with STGD1 when they report
reduced vision or when it is discovered at a routine check up. Vision function can vary greatly from
normal visual acuity to severely reduced.77 It is considered as a stationary disease until a greater
age. Then, atrophic changes are observed with associated reduction in vision. Retinal layer integrity
and cell-cell interaction excluding photoreceptors are considered as the primary abnormal
component in XLRS.
We examined patients of different ages with XLRS and identified mutation in XLRS1 using FD-
OCT to investigate the extent of photoreceptor involvement. (Ref. 10)31 Our data showed that
photoreceptors are indeed affected. (Fig. 19)
Figure 19: Schisis localization is demonstrated in the foveal and extrafoveal region. Schisis extent
is larger in younger patients and ‘flattens’ with age. Structural changes within photoreceptor
layers are more progressed with greater age.
Retinal schisis involved different retinal layers: inner plexiform to outer plexiform layers in the
foveal region. Outer and inner nuclear and ganglion cell layers showed splitting in the extrafoveal
area. Foveal outer and inner segment layers demonstrated irregularities and thinning with increasing
Figure 18: Retinal splitting of the central macula
is shown in a 6-year old boy with XLRS.
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patients’ age. Verhoeff’s membrane, the interface between cone photoreceptor and RPE cells, was
present in only the youngest patient tested and only in the extrafoveal area. There was no Verhoeff’s
membrane visible in all patients in the fovea, indicating a disruption of photoreceptor structure.
Comparison of type of mutation or vision function with retinal morphology did not reveal a
correlation. Higher age, in contrast, was associated with more progressed micro-structural retinal
abnormalities.
4. CONCLUSION
MfERG and high resolution Fd-OCT techniques are powerful investigative tools to characterize
phenotype variations in patients with various macular dystrophies. Both techniques provide results,
which give together with other clinical parameter a comprehensive evaluation. Our results support
that these methods are fundamental objective measures in patients with retinal dystrophies.
Prerequisite for these investigations were extensive mfERG studies of aging effects and  its
origin.12, 13
Morphological and functional data are important to quantify underlying retinal dysfunction and
structural changes to test for possible disease causing gene mutation. This is important particularly
in less obvious phenotypes. For example, schisis identification by OCT together with fullfield ERG
abnormalities will lead to investigation in the XLRS1 gene. Extensive reduction in mfERG
responses is seen more likely in patients STGD1 than in patients with autosomal dominant drusen.
These data can guide molecular-genetic investigations.
We showed that the mfERG is a reliable objective measure of retinal function in longitudinal
studies in patients with AMD.15 Latency shifts in mfERG responses point to early disease
abnormalities as shown in patients with large drusen in AMD.14, 15 A careful achieved database
together with a sophisticated data analysis allowed us to draw conclusions in respect to changes
over time.
Morphology in retinal dystrophies was until recently only available in histological sections. Now,
in-vivo OCT results can be compared with histological data. For example, patho-histological data
support our findings of sub RPE deposits in autosomal dominant drusen.78, 79 We showed that
retinal deposits in patients with STGD146, autosomal dominant drusen52, MPGN type II80 or
autosomal recessive bestrophin retinopathy66 are of different retinal localization and extent.
Investigation of the different photoreceptor layers in relation to retinal deposits is important for
understanding disease mechanism. Are the deposits the primary site of pathology and associated
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with inner and outer segment changes? For example, deposits in patients with BBS10 might be
related to the fast time course of retinal degeneration in advanced disease stages with retinal re-
organization.29
Functional and morphological results using mfERG and FD-OCT are important to verify disease
hypothesis and animal models. Retinal structure changes in the efemp1 retinal dystrophy mice
model with deposits between the plasma and basement membrane of RPE cells parallel our in-vivo
results in humans.81, 82 Mice with Bbs4 mutation showed similar changes compared with our FD-
OCT human data with photoreceptor thinning and shortening of inner and outer segment layers.83
Histopathological sections in patients with retinoschisis84, murine models with rs1-/y and our results
overlap in demonstrating focal and generalized photoreceptor abnormalities.
Visualization of distinct retinal changes will add to our understanding of gene function.
Retinoschisin, the protein product of XLRS1 expressed in photoreceptors and bipolar cells, is
important to maintain retinal cell-cell interactions.85 Our findings with retinal bridges between
schitic areas are supportive of these findings.
Future studies will aim to quantify retinal changes early in disease process. The development of the
flexible and modifiable FD-OCT unit with the hand-held scanner and possibly the application of
adaptive optic system will permit retinal examination in patients any ages on cellular level.
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